ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 583
    A Biomarker of Type VI Collagen Degradation (C6M) Is Associated with Changes in ASDAS MRI Measures of Inflammation in Patients with Axial Spondyloarthritis During TNF Inhibitor Therapy
  • Abstract Number: 2835
    A Burden of Missense Genetic Variants in Urate Secretory Genes Is Associated with Inadequate Response to Allopurinol in People with Gout
  • Abstract Number: 1071
    A Common Transcriptional Signature Is Present in Circulating Classical Monocytes and Skin Macrophages in Systemic Sclerosis
  • Abstract Number: 511
    A Comparative Analysis of Upadacitinib Monotherapy and Upadacitinib Combination Therapy for the Treatment of Rheumatoid Arthritis from Two Phase 3 Trials
  • Abstract Number: 1355
    A Comparison of Clinical Improvement Following a Major Therapeutic Change Utilizing Updated Treatment Thresholds Defined by Three Different Disease Activity Measures
  • Abstract Number: 1354
    A Comparison of Convergent Validity and Sensitivity to Change of the Conventional Scoring Method to Alternative Scoring Methods of the Health Assessment Questionnaire in Rheumatoid Arthritis
  • Abstract Number: 2585
    A Comparison of Risk of Ovarian Failure Following Intravenous Cyclophosphamide Therapy in Juvenile versus Adult Systemic Lupus Erythematosus
  • Abstract Number: 524
    A Comparison of Upadacitinib Plus Methotrexate and Upadacitinib Plus Other CsDMARDs in Patients with Rheumatoid Arthritis: An Analysis of Two Phase 3 Studies
  • Abstract Number: 2012
    A Composite IFN-Based Signature Is Associated with a Filgotinib-Specific Clinical Response in bDMARD-Experienced Rheumatoid Arthritis Patients
  • Abstract Number: 2841
    A Double-Blind, Placebo-Controlled, Phase 2 Trial of a Novel Toll-Like Receptor 7/8/9 Antagonist (IMO-8400) in Dermatomyositis
  • Abstract Number: 1968
    A Drug Repurposing Story: New Therapeutic Tools Ready to Block Innate Immune Responses in Osteoarthritis
  • Abstract Number: 2630
    A Dutch Consensus Statement on the Diagnosis and Treatment of ANCA Associated Vasculitis
  • Abstract Number: 219
    A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
  • Abstract Number: 1768
    A First-in-class Selective and Potent IRAK4 Degrader Demonstrates Robust in Vitro and in Vivo Inhibition of TLR/IL-1R Activation and Inflammation
  • Abstract Number: 2184
    A Flexion Contracture Is a Risk Factor for Radiographic Progression and Earlier Need for Arthroplasty in Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 224
    A Functional Exercise Program Improves Pain and Health Related Quality of Life in Patients with Fibromyalgia: A Randomized Controllel Trial
  • Abstract Number: 2443
    A Gender-based Analysis of Disease Activity and Its Relationship with Anxiety, Depression, Fatigue, and Fibromyalgia in Psoriatic Arthritis
  • Abstract Number: 1966
    A Genome-Wide Association Study of Copy Number Variations Identifies the Deletion Associated with Efficacy of TNF-Alpha Blocker Therapy in Korean Patients with Rheumatoid Arthritis
  • Abstract Number: L20
    A Head-to-Head Comparison of Ixekizumab and Adalimumab in Biologic-Naïve Patients with Active Psoriatic Arthritis: Efficacy and Safety Outcomes from a Randomized, Open-Label, Blinded Assessor Study Through 52 Weeks
  • Abstract Number: 192
    A Healthy Plant-Rich Diet and the Risk of Rheumatoid Arthritis in Women
  • Abstract Number: L18
    A Human Recombinant Fusion Protein Targeting B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (APRIL), Telitacicept (RC18), in Systemic Lupus Erythematosus (SLE): Results of a Phase 2b Study
  • Abstract Number: 1782
    A Human SLE Variant NCF1-R90H Drives Lupus-like Kidney Disease in a Pristane-induced Murine Lupus Model
  • Abstract Number: 2187
    A Low Cartilage Formation & Repair Endotype Predicts Radiographic Progression in Symptomatic Knee Osteoarthritis Patients and Identifies Optimal Responders to a Potential OA Treatment
  • Abstract Number: 1126
    A Medical Assistant Driven Quality Improvement Intervention Increases Rates of DEXA Screening Among RA Patients
  • Abstract Number: 646
    A Meta-Analysis of Anti-Ribosomal P Autoantibodies in Systemic Lupus Erythematosus: A Misunderstood Autoantibody
  • Abstract Number: 54
    A Metagenome-wide Association Study of Gut Microbiome Revealed Novel Etiology of Rheumatoid Arthritis in the Japanese Population
  • Abstract Number: L09
    A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial
  • Abstract Number: 1215
    A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-Ranging Study to Evaluate Efficacy and Tolerability of SHR4640 in Patients with Hyperuricemia
  • Abstract Number: 2290
    A Multicentre Study of 244 Pregnancies in Women with Undifferentiated Connective Tissue Disease: Foetal/Perinatal and Maternal Outcomes and Disease Evolution Towards a Definite Connective Tissue Disease
  • Abstract Number: 1847
    A National Needs Assessment of Males with SLE: Assessing Medical, Psychosocial, Support & Coping Needs
  • Abstract Number: 1227
    A Neutrophil Signature Is Strongly Associated with Cardiovascular Risk in Gout
  • Abstract Number: 1166
    A New Risk Factor for Predicting the Long-term Outcome of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Pulmonary Artery Size Measured by Chest Computed Tomography
  • Abstract Number: 2812
    A New Role for Selectins in Systemic Lupus Erythematosus
  • Abstract Number: 2176
    A Novel Composite Score Reflecting Disease Activity Predicts Future Knee Replacements: Data from the Osteoarthritis Initiative
  • Abstract Number: 755
    A Novel Diagnostic Algorithm for Polymyalgia Rheumatica Using Three Musculoskeletal Sites on Whole Body PET/CT
  • Abstract Number: 959
    A Novel Image Analysis Program, “CytoSkaler”, Demonstrates That Anti-Vimentin Antibody Affinity Maturation in Lupus Tubulointerstitial Nephritis Also Results in More Selective Antigen Targeting
  • Abstract Number: 641
    A Novel Method to Analyze Circulating Immune Complexes Predicts Disease Activity and Severity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
  • Abstract Number: 1536
    A Novel MK2 Inhibitor for the Treatment of Ankylosing Spondylitis and Other Inflammatory Diseases
  • Abstract Number: 424
    A Novel Patient-Reported Outcome Measure in IgG4-Related Disease: The Symptom Severity Index
  • Abstract Number: 6
    A Novel Role for Extracellular Sulfatase-2 in Mediating IL-6-induced Adhesion and Migration Molecules in Human Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 982
    A Novel Role for Nod2 in Controlling Autoantibody Production and Arthritis in SKG Mice
  • Abstract Number: 55
    A Novel Subclass of Intravascular Non-classical, Tissue Resident Synovial Monocyte Is Critical for Rheumatoid Arthritis Pathogenesis
  • Abstract Number: 828
    A Path Model Analysis of the Cognitive Determinants of Physical Activity Among Patients with Fibromyalgia (FM)
  • Abstract Number: 943
    A Phase 1b/2a Trial of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus
  • Abstract Number: 2760
    A Phase 2 Double-Blind Clinical Trial to Examine the Comparative Effects on Osteoarthritic Knee Pain of CGS-200-1 (1% Capsaicin Topical Liquid), CGS-200-5 (5% Capsaicin Topical Liquid), and CGS-200-0 (Vehicle, No Capsaicin)
  • Abstract Number: 532
    A Phase 2 Study of E6011, an Anti-Fractalkine Monoclonal Antibody, ㏌ Patients with Rheumatoid Arthritis Inadequately Responding to Biologics
  • Abstract Number: 2559
    A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of Anifrolumab in Adults with Systemic Lupus Erythematosus
  • Abstract Number: 2417
    A Phase 2a Study of MEDI5872 (AMG557), a Fully Human Anti-ICOS Ligand Monoclonal Antibody in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 1763
    A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
  • Abstract Number: 827
    A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL) for the Treatment of Fibromyalgia (FM): Evidence for a Broad Spectrum of Activity on the FM Syndrome
  • Abstract Number: 2771
    A Phase I, Randomized, Double-blind, Placebo-controlled, Single Center, Single-dose Escalation to Investigate the Safety, Tolerability, and Pharmacodynamics of Subcutaneously Administered DEN-181 in Adult Patients with ACPA+ Rheumatoid Arthritis on Stable Methotrexate
  • Abstract Number: 939
    A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obinutuzumab or Placebo in Combination with Mycophenolate Mofetil in Patients with Active Class III or IV Lupus Nephritis
  • Abstract Number: 503
    A Pilot Phase 1, Randomized, Double-blind, Two-arm, Parallel Group, Single-dose Study to Evaluate the Safety and Pharmacokinetics of CT-P17 and Humira in Healthy Male Subjects
  • Abstract Number: 2270
    A Pilot Study of the Psychosocial Impact of Undifferentiated Connective Tissue Disease
  • Abstract Number: 514
    A Pooled Analysis of 1-year Clinical Outcomes Among 6-month Responders and Non-responders from Three Randomized Controlled Studies of TNF Inhibitor Biosimilars in Patients with Rheumatoid Arthritis
  • Abstract Number: 220
    A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
  • Abstract Number: 319
    A Pragmatic Randomized Trial to Improve Safe Dosing of Hydroxychloroquine
  • Abstract Number: 2408
    A Prospective Analysis of Factors Impacting Medication Decision-Making in Patients with Rheumatoid Arthritis
  • Abstract Number: 1307
    A Prospective, Multi-center, Randomized, Clinical Trial Comparing the Effectiveness and Safety of Cooled Radiofrequency Ablation versus a Single Injection of Hyaluronic Acid in the Management of OA Knee Pain
  • Abstract Number: 155
    A Prospective, Unblinded, Non-randomized Pilot Study Examining the Effect of a Musculoskeletal Immersion Curriculum for First Year Internal Medicine Residents
  • Abstract Number: 2263
    A Qualitative Study Evaluating Near-Patient Tools Including a Mobile Application for Earlier RA Referral; Potential to Reduce Chronic Disease Burden
  • Abstract Number: 2512
    A Qualitative Study of Clinicians’ Perspectives on Barriers to Implementation of Treat to Target in Psoriatic Arthritis
  • Abstract Number: 147
    A Qualitative Study of Factors That Influence Interest in a Career in Pediatric Rheumatology
  • Abstract Number: 2095
    A Quality Improvement Intervention to Improve Influenza and Pneumococcal Vaccination Rates in Immunosuppressed Inflammatory Arthritis Outpatients
  • Abstract Number: 1207
    A Quality Improvement Intervention to Reduce 30-Day Hospital Readmission Rates Among Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2579
    A Quality Improvement Project in Determining If Cardiac Enzymes Play a Role in Surveillance of Possible Hydroxychloroquine Induced Cardiotoxicity
  • Abstract Number: 1190
    A Quality Improvement Project to Increase Documentation Efficiency in an Academic Rheumatology Practice
  • Abstract Number: 1809
    A Quarter of Patients Treated with Checkpoint Inhibitors Develop Immune-Related Adverse Events: A University Center Experience
  • Abstract Number: 1298
    A Randomised Clinical Trial of Curcuma Longa Extract for Treating Symptoms and Effusion-Synovitis of Knee Osteoarthritis
  • Abstract Number: 2167
    A Randomised Controlled Clinical Trial Comparing the Effectiveness of 6 and 12 Weeks of a Shoulder Specific Exercise Programme for Patients with Rotator Cuff Related Shoulder Pain
  • Abstract Number: 2911
    A Randomised, Open Labelled Clinical Trial to Investigate Synovial Mechanisms Determining Response – Resistance to Rituximab versus Tocilizumab in Rheumatoid Arthritis Patients Failing TNF Inhibitor Therapy
  • Abstract Number: 539
    A Randomized Double-Blind Study Comparing Pharmacokinetics (PK) and Pharmacodynamics (PD) of ABP 798 with Rituximab in Subjects with Moderate to Severe RA
  • Abstract Number: 942
    A Randomized Prospective Trial to Assess the Clinical Utility of Multianalyte Assay with Complement Activation Products in Diagnosing Systemic Lupus Erythematosus
  • Abstract Number: 806
    A Randomized, Controlled Trial of Rituximab versus Azathioprine After Induction of Remission with Rituximab for Patients with ANCA-associated Vasculitis and Relapsing Disease
  • Abstract Number: 1240
    A Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Anakinra in Difficult-To-Treat Acute Gouty Arthritis: The anaGO Study
  • Abstract Number: 1498
    A Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Secukinumab in US Biologic-Naive Patients with Active Psoriatic Arthritis and Psoriatic Skin Lesions
  • Abstract Number: 1675
    A Retrospective Cohort Study Using Clinical Notes and Latent Topic Modeling to Characterize the Natural History of ANCA-Associated Vasculitis
  • Abstract Number: 1254
    A Retrospective Medical Chart Review of Patients with Periodic Fever Syndromes Initiating Canakinumab in the United States
  • Abstract Number: 1213
    A Retrospective Review and Prospective Intervention for Outpatient Follow-Up of Hospitalized Patients in Rheumatology
  • Abstract Number: 2718
    A Retrospective Study Comparing Refractoriness to Biologic Disease Modifying Anti-Rheumatic Drugs in Adults with Juvenile Idiopathic Arthritis as Compared to Those with Rheumatoid Arthritis
  • Abstract Number: 1964
    A Role for Microbiota in the Pathophysiology of Takayasu Arteritis (TAK) and Giant Cell Arteritis (GCA)
  • Abstract Number: 1885
    A Search to the Target Tissue in Which RA-specific Inflammation Starts: A Detailed MRI Study to Improve Identification of RA-specific Features in the Phase of Clinically Suspect Arthralgia
  • Abstract Number: L07
    A Serum Proteomic Signature Defines Transition from the Preclinical State to Rheumatoid Arthritis
  • Abstract Number: 162
    A Shared Mental Model for Teaching and Assessing Examination of the Hand, Wrist, and Elbow in the “Training Rheum” Continuing Professional Development Program
  • Abstract Number: 152
    A Shoulder to Lean On: Differences in Shoulder Examinations Between Rheumatology Educators and Fellows
  • Abstract Number: 2622
    A Single Center Retrospective Analysis of Efficacy and Safety Between Low-Dose versus High-Dose Rituximab as Remission Induction Therapy with ANCA-Associated Vasculitis
  • Abstract Number: 895
    A Spatial-temporal Analysis of Organ-specific Lupus Flares in Relation to Fine Particulate Matter Pollution and Temperature
  • Abstract Number: 517
    A Subgroup Analysis of Clinical Efficacy Response and Quality of Life Outcomes from Phase 3 Study of Filgotinib in Patients with Inadequate Response to Biologic DMARDs
  • Abstract Number: 504
    A Subgroup Analysis of the Efficacy of Filgotinib in Demographic and Clinical Subgroups of Patients with Refractory Rheumatoid Arthritis
  • Abstract Number: 1751
    A Systematic Literature Review of Efficacy and Safety of Biologic Agents for the Treatment of Juvenile Dermatomyositis
  • Abstract Number: 253
    A Systematic Review and Meta-analysis of Observational Studies Reporting on the Use of Checkpoint Inhibitors in Patients with Cancer and Pre-existing Autoimmune Disease
  • Abstract Number: 731
    A Systemic Review of Factors Associated with Systemic Sclerosis-associated Pulmonary Arterial Hypertension (SSc-PAH)
  • Abstract Number: 705
    A Tale of Three Cohorts: SLE Criteria in Developed vs Developing Countries
  • Abstract Number: 2661
    A Ten-Year Retrospective Review of Temporal Artery Biopsy Lengths in Alberta
  • Abstract Number: 905
    A Third of Relapsing Polychondritis Patients with Ear Involvement at Presentation Had Airway Involvement at the Last Follow-up with a High Mortality Rate
  • Abstract Number: 200
    A Validated Text-mining Algorithm to Extract Rheumatoid Arthritis Medication Contained in Format-free Fields of Electronic Medical Records
  • Abstract Number: 756
    A Volar Pattern of 18F-Fluorodeoxyglucose Uptake at the Hand on Whole Body PET/CT Predicts Glucocorticoid-Responsive Disease in Polymyalgia Rheumatica
  • Abstract Number: 2220
    Abaloparatide Followed by Alendronate on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
  • Abstract Number: 2548
    Abatacept Failed to Demonstrate Efficacy in an SLE Trial with Low Placebo Response Rates, Although Global Assessments Indicated Less Flare Severity
  • Abstract Number: 2345
    Abatacept in Rheumatoid Arthritis with Interstitial Lung Disease: A Retrospective Multicenter Study of 263 Patients
  • Abstract Number: 1907
    Abatacept Reduces Serum CXCL13 and Disease-Relevant Immune Cell Phenotypes in a Double-Blind, Placebo-Controlled Primary Sjögren’s Syndrome Clinical Trial
  • Abstract Number: 1065
    Aberrant Expression Levels of Soluble Co-inhibitory Receptors Linked to Disease Activity in Systemic Sclerosis
  • Abstract Number: 2029
    Aberrant H3K9me3 Modification in Promoter Region Up-regulates cAMP Response Element Modulator Alpha in Systemic Lupus Erythematosus
  • Abstract Number: 30
    Aberrant M1 Polarization of Macrophages in Behcet’s Disease
  • Abstract Number: 32
    Aberration of Histone Lysine Methylation in Adult-Onset Still’s Disease Are Novel Biomarker Candidates Associated with the Disease Activity
  • Abstract Number: 1829
    Ability of Inflammatory and Regulatory Soluble Mediators to Forecast Impending Clinical Disease Flare and Inform a Refined Lupus Flare Prediction Index in a Confirmatory Cohort of SLE Patients
  • Abstract Number: 1292
    Abnormal High Density Lipoprotein Particle Size and Number in Idiopathic Inflammatory Myopathies
  • Abstract Number: 2623
    Abnormality of Percentages and Absolute Numbers of CD4+ Memory and Regulatory T Subset Cells in ANCA-associated Vasculitis
  • Abstract Number: 2869
    Access to Care and Diagnostic Delays in Juvenile Dermatomyositis
  • Abstract Number: 185
    Accrual of Multimorbidity After Incident Rheumatoid Arthritis and Matched Comparators Using a Large Prospective Cohort with 30 Years of Follow-up
  • Abstract Number: 190
    Accuracy of Administrative Algorithms for Identifying Interstitial Lung Disease in Rheumatoid Arthritis
  • Abstract Number: 2635
    Accuracy of Self-Reported Diagnosis of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  • Abstract Number: 1516
    Achievement of RAPID3 and cDAPSA Treatment Targets Is Associated with Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in Subjects Treated with Apremilast
  • Abstract Number: 1347
    Achievement of Remission in Two Early Rheumatoid Arthritis Cohorts Implementing Different Treat-To-Target Strategies
  • Abstract Number: 1535
    Achievement of Very Low Disease Activity and Remission Treatment Targets Is Associated with Reduced Radiographic Progression in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol
  • Abstract Number: 2503
    Achilles Tendon Enthesitis and Disease Burden in Psoriatic Arthritis and Axial Spondyloarthritis: Baseline Results from a Randomized Controlled Trial
  • Abstract Number: 2353
    ACPA Testing and Resultant Treatment Patterns in Patients with Rheumatoid Arthritis: Findings from US Community Rheumatology Practices
  • Abstract Number: 450
    ACPA-positive versus ACPA-negative Rheumatoid Arthritis: Two Distinct Erosive Disease Entities on Radiography and Ultrasonography
  • Abstract Number: 389
    ACR/EULAR Criteria for Myositis and Systemic Sclerosis Lack Sensitivity for Scleromyositis
  • Abstract Number: 53
    Activation of the Desacetylase Sirtuin-1 Counteracts the Activated and Proangiogenic Profile of Endothelial Cells in Rheumatoid Arthritis and Alleviates Experimental Arthritis
  • Abstract Number: 2807
    Activation of the STING Pathway Is a Shared Feature of Salivary Gland and Lung Inflammation in Sjogren’s Syndrome
  • Abstract Number: 2082
    Activity in Work and Life: The Association Between Physical Activity and Employment Status with Future Slow Walking in Knee Osteoarthritis
  • Abstract Number: 222
    Acupuncture for Chronic Musculoskeletal Pain: A Review of Randomized Controlled Trials
  • Abstract Number: 1435
    Acute Effects of IL-6 Blockade, TNFα Inhibitor or Glucocorticoids on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis
  • Abstract Number: 330
    Acute Gout Attacks Among Patients Admitted Due to Heart Failure: Analysis of NIS Database
  • Abstract Number: 2133
    Acute Myocardial Infarction in Rheumatoid Arthritis, Gout, and Osteoarthritis: A Retrospective Study Using the National Inpatient Sample from 2002-2016
  • Abstract Number: 2700
    Adalimumab Alone Is Superior to Adalimumab Plus Methotrexate in Juvenile Idiopathic Arthritis Associated Uveitis: Data from the ORCHIDEA Registry
  • Abstract Number: 1679
    Adaptive Study Design of a Randomized, Multicenter, 2-Part Phase 2 Trial of Replacement of Glucocorticoids by IFX-1, a C5a Inhibitor, in Active Granulomatosis with Polyangiitis and Microscopic Polyangiitis
  • Abstract Number: 135
    Added Clinical Utility of Testing for Extra-Criteria Antibodies Specificities Beyond Sapporo and Sydney Criteria Recommendations
  • Abstract Number: 158
    Addressing the Pediatric Rheumatology Physician Shortage: Does Early Exposure Matter?
  • Abstract Number: 1992
    Adenosine A2A Receptor (A2AR) Stimulation Mitigates Mitochondrial Inflammaging, Enhances Mitochondrial Metabolism and Reduces Reactive Oxygen Species-Mediated Mitochondrial Injury In Vitro and In Vivo in Osteoarthritis
  • Abstract Number: 890
    Adenosine A2A Receptor Signaling Activates FoxO1 and FoxO3 and Promotes Cartilage Autophagy
  • Abstract Number: 1967
    Adenosine A2A Receptor Signals Through AMPK and SIRT1 to Increase Chondrocyte Homeostasis
  • Abstract Number: 920
    Adenosine Deaminase 2 as a Circulating Biomarker of Macrophage Activation Syndrome
  • Abstract Number: 248
    Adherence to Biologic Disease-modifying Anti-rheumatic Drugs (DMARDs) —a Comparison of Long-term Adherence Among Patients with Various Inflammatory Conditions by Primary Dispensing Channel
  • Abstract Number: 324
    Adherence to Guideline Directed Management of Gout Among VA Providers
  • Abstract Number: 2564
    Adherence to Hydroxychloroquine Influences the Incidence of Organ Damage During Follow-up in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 955
    Adherence to Statin Therapy in Rheumatoid Arthritis Patients: A Population-Based Cohort Study
  • Abstract Number: 2255
    Adherence to Subcutaneous Anti-tnf Therapies in Chronic Inflammatory Rheumatism and Therapeutic Education
  • Abstract Number: 1372
    Adherence to Treatment with Intravenous Biological Agents in Patients with Rheumatoid Arthritis
  • Abstract Number: 321
    Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Rheumatoid Arthritis and Systemic Lupus Erythematosus
  • Abstract Number: 981
    Adipocytokines and Obesity in the Context of Rheumatoid and Osteoarthritis Mouse Models
  • Abstract Number: 691
    Adjusted GAPSS in Systemic Lupus Erythematosus Patients in Argentina
  • Abstract Number: 120
    Administration of a CD45 Antibody Drug Conjugate as a Novel, Targeted Approach to Achieve Immune System Reset: A Single Dose of CD45-targeted ADC Safely Conditions for Autologous Transplant and Ameliorates Disease in Multiple Models of Autoimmune Disease
  • Abstract Number: 1721
    Adult Primary Central Nervous System Vasculitis Treatment and Course: A Long-term Follow-up Study
  • Abstract Number: 1271
    Adult-Onset Still’s Disease Prognosis Score: Clinical Patterns, Complications and Biologic Treatment
  • Abstract Number: 1247
    Adult-Onset Still’s Disease and Spondyloarthritis: Overlapping Syndrome or Incidental Association? A Series of 5 Cases
  • Abstract Number: 2871
    Advances in Treatment of Rheumatoid Arthritis: ACPA-positive Patients Benefited More Than ACPA-negative Patients; 25 Year Results of a Longitudinal Cohort Study
  • Abstract Number: 2653
    Adventitial Fibroblast, an Important Actor in Giant Cell Arteritis
  • Abstract Number: 892
    Adverse Childhood Experiences Are Associated with Systemic Lupus Erythematosus in a Clinical Population from Bronx, New York
  • Abstract Number: 328
    Adverse Events During Colchicine Use: A Systematic Review and Meta-Analysis of Randomized Controlled Trial Events
  • Abstract Number: 2403
    Adverse Events of Special Interest in Patients with Rheumatoid Arthritis Treated with Peficitinib in Asian Population: Pooled Safety Findings
  • Abstract Number: 858
    Adverse Events of Special Interest, SLE Medication Utilization, Hospitalizations, and Organ Damage: Results from a Phase 4, Randomized, Double-Blind, Placebo-Controlled, 52-week Study of Belimumab in Adults with Active, Autoantibody-Positive SLE
  • Abstract Number: 1364
    Affect of Obesity on Multi-Biomarker Disease Activity (MBDA) Measurements in Rheumatoid Arthritis (RA) Patients
  • Abstract Number: 674
    Affordability Concerns Prevalent Among Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 639
    African-American Risk of Proteinuria After SLE Diagnosis Increases Throughout Thirty Years of Followup
  • Abstract Number: 1266
    AGBL3 as a Novel Gene Associated with Hereditary Hypocomplementemic Urticarial Vasculitis and Favorable Response to Rituximab
  • Abstract Number: 1957
    Aggregation of Functional Variants in NOTCH4 Gene Increases SSc Risk
  • Abstract Number: 2723
    Alagille Syndrome and Chronic Arthritis: An International Case Series
  • Abstract Number: 2778
    Alcohol Consumption as a Predictor of the Progression of Spinal Structural Damage in Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)
  • Abstract Number: 2069
    Alcohol Consumption Is Not an Independent Predictor of Fatigue Severity over Time
  • Abstract Number: 257
    Alcohol Use Hospitalizations in People with Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain Are Increasing: A Time-trends Study Using the U.S. National Data
  • Abstract Number: 1984
    Alendronate-CGS21680 Conjugates Prevent Bone Erosion in a Murine Osteolysis Model but Not in A2A KO Mice
  • Abstract Number: 1586
    All-cause Hospitalizations and Mortality in Systemic Lupus Erythematosus in the US- results from a National Inpatient Database
  • Abstract Number: 581
    Allograft Inflammatory factor-1 Drives Th17 Like Pathologic Signature and Predict Poor Response to TNF Inhibitor in Ankylosing Spondylitis
  • Abstract Number: 353
    Allopurinol Use and Type 2 Diabetes Incidence Among Patients with Gout: A VA Cohort Study
  • Abstract Number: 2416
    ALPN-101, a First-in-Class Dual ICOS/CD28 Antagonist, Suppresses Key Effector Mechanisms Associated with Sjögren’s Syndrome
  • Abstract Number: 1531
    ALPN-101, a First-in-Class Dual ICOS/CD28 Antagonist, Suppresses Key Effector Mechanisms Underlying Rheumatoid and Psoriatic Arthritis
  • Abstract Number: 1294
    Alterations in Activin A-Myostatin-Follistatin System Associate with Disease Activity in Inflammatory Myopathies
  • Abstract Number: 957
    Alterations in Cholesterol Homeostasis Regulate Autoimmunity/Age-associated B Cells
  • Abstract Number: 2784
    Alterations in Inflammatory, TNF-Superfamily, and IFN-Associated Chemokines Precede Clinical Changes in SLEDAI After Methylprednisolone Treatment of SLE Patients
  • Abstract Number: 963
    Alterations of Memory and Naive B Cell Subsets Associate with Reduced IFNα and TNFRII in ANA+ Healthy Individuals
  • Abstract Number: 25
    Altered Distribution and Enhanced Osteoclastogenesis of Mucosal-associated Invariant T Cells in Gouty Arthritis
  • Abstract Number: 2744
    Altered Expression of CD52 Facilitates Adhesion of Circulating CD14+ Monocytes in Systemic Sclerosis
  • Abstract Number: 27
    Altered Inflammatory Response of Macrophages in the Fosl-2 Transgenic Mouse Model of Systemic Sclerosis
  • Abstract Number: 66
    Amelioration of Immune Complex-Mediated Glomerulonephritis by CD6 Modulation
  • Abstract Number: 725
    Amniotic Membrane Dressings Provide an Effective Treatment for Systemic Sclerosis Digital Ulcers
  • Abstract Number: 4
    AMP Deaminase 2 Surface Expression Counteracting CD73-Driven Generation of Anti-Inflammatory Extracellular Adenosine
  • Abstract Number: 1701
    Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road
  • Abstract Number: 166
    An Analysis of Inpatient Rheumatology Consults at an Academic Military Medical Center over 16 Years: Do Consults Requests Accurately Reflect the Curriculum and Prepare Fellows for Board Certification and Future Practice?
  • Abstract Number: 1367
    An Engineered Glove for the Computerised Quantification of Hand Disability in Rheumatoid Arthritis
  • Abstract Number: 1794
    An Evaluation of Burnout Among U.S. Rheumatology Fellows: A National Survey
  • Abstract Number: 2419
    An ex-vivo Assay to Evaluate the Efficacy of Different Treatments for Inhibiting B Lymphocytes Activation by Salivary Gland Epithelial Cells in Sjögren’s Syndrome
  • Abstract Number: 421
    An Examination of Patient-Reported Outcomes Data from a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis
  • Abstract Number: 2816
    An Expanded Granzyme K+ CD8 T Cell Population Induces Inflammatory Responses in Rheumatoid Arthritis Synovium
  • Abstract Number: 2885
    An Integrated Gut Microbiomic and Plasma Metabolomic Analysis in Patients with Four Systemic Autoimmune Diseases
  • Abstract Number: 2096
    An Intervention Bundle Increases Uptake of Influenza Vaccine by Rheumatoid Arthritis Patients
  • Abstract Number: 632
    An Observational Analysis of the Co-existence of Brugada Syndrome in Patients with Spondyloarthritis; A Potentially Important Link
  • Abstract Number: 2542
    An Updated Meta-Analysis of the Efficacy and Safety of Mycophenolate Mofetil in the Induction Treatment of Chinese Patients with Lupus Nephritis
  • Abstract Number: 307
    ANA-lysis: Utility of Repeated Antinuclear Antibody Testing in a Single Center
  • Abstract Number: 2901
    Anakinra Treatment in Patients with Familial Mediterranean Fever: A Single-center Experience
  • Abstract Number: 1243
    Anakinra Treatment in Recurrent Pericarditis: Single Center Experience
  • Abstract Number: 561
    Analysing Impairments in Physical Performance as Assessed by the as Performance Index (ASPI) in Patients with Axial Spondyloarthritis (axSpA)
  • Abstract Number: 1436
    Analysis of Adverse Events of Methotrexate (MTX), bDMARDs and Tofacitinib (TOFA) Reported to Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Abstract Number: 1939
    Analysis of Discoid Lupus Erythematosus (DLE) Gene Expression Reveals Dysregulation of Pathogenic Pathways Associated with Infiltrating Immune/Inflammatory Cells
  • Abstract Number: 2022
    Analysis of Gene Expression from Systemic Lupus Erythematosus Synovium Reveals Unique Pathogenic Mechanisms
  • Abstract Number: 1930
    Analysis of Lupus Nephritis Gene Expression Reveals Dysregulation of Pathogenic Pathways Activated Within Infiltrating Cells
  • Abstract Number: 1054
    Analysis of Serum Markers Across the Scleroderma Spectrum Shows Subset and Stage Specific Profiles of Fibrogenesis
  • Abstract Number: 2634
    ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
  • Abstract Number: 2642
    ANCA Testing: Final Diagnoses in Cases with Positive Immunofluorescence and Negative ELISA
  • Abstract Number: 871
    ANCA-Associated Vasculitis Management in the United States: Data from the RISE Registry
  • Abstract Number: 2025
    Ancestry Influences the Gene Expression Profile in Systemic Lupus Erythematosus and Contributes to Transcriptomic Heterogeneity in Lupus Patients
  • Abstract Number: 2916
    Ancestry-Specific Classical HLA Alleles Define Phenotypic Subsets in the African American Scleroderma Population
  • Abstract Number: 1369
    Angiogenic Factors for Assessing Rheumatoid Arthritis in the Era of Sonographic Diagnosis and Biologic Therapy
  • Abstract Number: 768
    Angiographic Patterns and Changes in Arterial Lesions in Patients with Behcet’s Disease
  • Abstract Number: 70
    Angiotensin Receptor Blockers Prevent Loss of Dendritic Complexity in a Lupus Mouse Model of Cognitive Impairment
  • Abstract Number: 610
    Ankylosing Spondylitis-associated Killer Immunoglobin-like Receptors Are Strongly Expressed on γδ T Cells
  • Abstract Number: 2609
    Anti-angiogenic VEGF-A165b Is Associated with Systemic Sclerosis Peripheral Vasculopathy
  • Abstract Number: 1882
    Anti-CCP Antibody and Pain Sensitization in Rheumatoid Arthritis
  • Abstract Number: 987
    Anti-citrullinated Protein Antibodies Induce Subclinical Inflammation, Bone Loss and Pain in Mice
  • Abstract Number: 452
    Anti-citrullinated Vimentin Antibodies Are Associated to Early Deterioration of Cortical Bone and Volumetric Bone Mineral Density in Finger Joints in RA-at-risk Patients
  • Abstract Number: 1021
    Anti-IFNAR Treatment Does Not Reverse Neuropsychiatric Disease in MRL/lpr Lupus Mice
  • Abstract Number: 2000
    Anti-inflammatory Effect of Novel Spleen Tyrosine Kinase Inhibitor, SKI-O-592, on Fibroblast-like Synoviocyte in Rheumatoid Arthritis and THP-1 Cell
  • Abstract Number: 405
    Anti-MDA5 Dermatomyositis: A Case Series, Systematic Review and Meta-analysis of the Literature
  • Abstract Number: 1887
    Anti-Mitochondrial Antibodies Predict Severe Erosive Disease in Rheumatoid Arthritis
  • Abstract Number: 1287
    Anti-mitochondrial Autoantibodies in Idiopathic Inflammatory Myopathies
  • Abstract Number: 1788
    Anti-neutrophil Extracellular Trap (NET) Autoantibodies in Primary Antiphospholipid Syndrome
  • Abstract Number: 1591
    Anti-ovarian Antibodies Are Not Associated with Premature Menopause in SLE Treated with Cyclophophosphamide
  • Abstract Number: 131
    Anti-Phosphatidylserine Prothrombin Antibodies as a Predictor of the LAC in an All-Comer Population
  • Abstract Number: 132
    Anti-phosphatidylserine/prothrombin Antibodies Confer a Distinctive Molecular Profile in Primary Antiphospholipid Syndrome Patients
  • Abstract Number: 2003
    Anti-Polygalacturonic Acid Antibody (PGA-Ab) Induced Bone Destruction in Rheumatoid Arthritis by Promoting Osteoclastogenesis via Integrin Beta 5
  • Abstract Number: 455
    Anti-Protein-Arginine Deiminase (PAD) 4 IgA Are Present in the Sera of Rheumatoid Arthritis Patients and Are Associated with Joint Erosion and Biological Treatment Use
  • Abstract Number: 2618
    Anti-RNPC-3 Antibodies Are Associated with Nuclear Speckled Immunofluorescence Pattern and Enriched in Triple Negative Systemic Sclerosis Patients
  • Abstract Number: 2103
    Anti-TNF Therapy in Patients with HIV Infection
  • Abstract Number: 2297
    Anti-TNF-α Exposure During Pregnancy: Impact on the Neonate’s Immune System
  • Abstract Number: 133
    Anti-β2GPI Domain 1 Antibodies Stratify High Risk of Thrombosis and Pregnancy Morbidity in a Large Cohort of Chinese Patients with Antiphospholipid Syndrome
  • Abstract Number: 2128
    Anti–MDA5 Antibody Positive Dermatomyositis Is Not Always Associated with Recalcitrant Lung Disease or Mortality
  • Abstract Number: 2824
    Antibiotic Use and the Development of Rheumatoid Arthritis (RA) and Risk of RA Flares: Case-Control and Self-Controlled Case Series Studies in Two National Electronic Patient Databases (SIDIAP and CPRD)
  • Abstract Number: 126
    Antibodies Targeting Mitochondrial Antigens Are Associated with Reduced Thrombotic Events in APS
  • Abstract Number: 2038
    Antibodies to Malondialdehyde-acetaldehyde (MAA) Protein Adduct as a Biomarker for Cardiovascular Manifestations in Systemic Lupus Erythematosus
  • Abstract Number: 482
    Antibody Repertoire Sequencing, Antigen Array Analysis, and Cytokine Profiling of Blood from Individuals at High-risk for RA Reveals Candidate Immunoglobulin V Genes, ACPA, and Cytokines That May Promote the Transition to Arthritis
  • Abstract Number: 1886
    Antibody Systems Targeting Citrullinated, Carbamylated, and Peptidyl Arginine Deaminase Autoantigens Distinguish Rheumatoid Arthritis in Combination with Rheumatoid Factors
  • Abstract Number: 1652
    Anticentromere Antibody Levels and Isotypes Associate with Disease Severity in Systemic Sclerosis
  • Abstract Number: 1289
    Antigen Bead Array versus ELISA to Detect anti-cN1A Antibodies in Patients with Sporadic Inclusion Body Myositis and Correlation with Clinical, Serological and Histological Features
  • Abstract Number: 2526
    Antimalarial Agents Improve Physical Functioning in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2555
    Antimalarial-Induced Cardiomyopathy: Outcome in 10 Patients
  • Abstract Number: 2873
    Antimicrobial Use Is High in Patients with Rheumatoid Arthritis, and Further Increases with First-Line TNFi Therapy – Nationwide Results from Iceland
  • Abstract Number: 142
    Antiphospholipid Antibodies Prevalence in Women with Late Pregnancy Complication and Low-Risk for Chromosomal Abnormalities
  • Abstract Number: 1791
    Antiphospholipid Antibody Profile Stability over Time: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
  • Abstract Number: 660
    Antiphospholipid Syndrome (APS) in Systemic Lupus Erythematosus (SLE) Leads to a More Severe Disease
  • Abstract Number: 139
    Antiphospholipid Syndrome Damage Index (DIAPS): Distinct Long-term Kinetic in Primary Antiphospholipid Syndrome and APS Related to SLE
  • Abstract Number: 144
    Antiphospholipid Syndrome-Associated Preeclampsia Is Defined by a Distinct Clinical Phenotype
  • Abstract Number: 2355
    Antirheumatic Therapy Is Associated with Reduced Complement Activation in Rheumatoid Arthritis
  • Abstract Number: 2356
    Antirheumatic Therapy Is Not Associated with Changes in Circulating N-terminal Pro-brain Natriuretic Peptide Levels in Patients with Active Rheumatoid Arthritis
  • Abstract Number: 409
    Antisynthetase Syndromes: Correlation of Indirect Immunofluorescence Patterns with Diagnosis Criteria Fulfillment
  • Abstract Number: 1950
    Apolipoprotein L1 Variant-Carrying Monocytes Exhibit Mitochondrial Respiration Defects
  • Abstract Number: 2230
    Applicability of FRAX in Clinical Practice: 10-year Results
  • Abstract Number: 2865
    Application of Bayesian Statistics to Support Approval of Intravenous Belimumab in Children with Systemic Lupus Erythematosus in the United States
  • Abstract Number: 765
    Application of Different Sets of Classification/diagnostic Criteria for Polymyalgia Rheumatica: Single Center Study of 100 Patients
  • Abstract Number: 784
    Application of Systems Biology-Based In Silico Tools for Optimal Treatment Strategy Identification in Still’s Disease
  • Abstract Number: 799
    Application of the Autoinflammatory Disease Activity Index (ADDI) to a Cohort of Patients in a Tertiary Hospital
  • Abstract Number: 1191
    Application of the Systemic Lupus Erythematosus (SLE) Quality Indicators in Patients Attending a Young Adult Transition Program
  • Abstract Number: 654
    Applying Systemic Lupus International Collaborating Clinics (SLICC) and Provisional ACR/EULAR Systemic Lupus Erythematosus Classification Criteria in a Cohort of Patients with Undifferentiated Connective Tissue Disease
  • Abstract Number: 1695
    Apremilast in Combination vs Monotherapy for Refractory Oral And/or Genital Ulcers in Behçet’s Disease: National Multicenter Study of 51 Cases
  • Abstract Number: 1012
    Apremilast Inhibits Immune Cells Support of Inflammatory Osteoclastogenesis
  • Abstract Number: 1224
    AR882, a Potent and Selective URAT1 Inhibitor with a Favorable Pharmacological, Pharmacokinetic and Toxicity Profile
  • Abstract Number: 1229
    AR882, a Potent and Selective Uric Acid Lowering Agent Acting Through Inhibition of Uric Acid Reuptake, Shows Excellent Pharmacokinetics and Pharmacodynamics in a Phase 1 Clinical Trial
  • Abstract Number: 744
    Are Hematologic Indexes Helpful in the Diagnosis and Prognosis of Polymyalgia Rheumatica?
  • Abstract Number: 2109
    Are Immunosuppressants a Risk Factor Associated with Mycobacterium Tuberculosis Infection in Colombian Patients with Systemic Lupus Erythematosus? A Case-control Study
  • Abstract Number: 1753
    Are Patterns of Early Disease Severity Predictive of Grade 12 Academic Achievement in Patients with Childhood-onset Chronic Rheumatic Diseases?
  • Abstract Number: 838
    Are PROMIS Measures Associated with Minimal Disease Activity in Psoriatic Arthritis?
  • Abstract Number: 1107
    Are Rheumatologists Correctly Identifying and Controlling Traditional Cardiovascular Risk Factors?
  • Abstract Number: 603
    Are the Modified New York and ASAS Criteria Interchangeable in the Classification of Patients with Spondyloarthritis with Radiographic Sacroiliitis?
  • Abstract Number: 762
    Are There Any Identifiable Triggers in Polymyalgia Rheumatica? A Matched-Control Study
  • Abstract Number: 1149
    Are There Country Differences in Disease Activity and Life Impact of Psoriatic Arthritis? An Analysis of 436 Patients from 14 Countries
  • Abstract Number: 1345
    Are There Differences in Efficacy and Safety of Biological Disease-modifying Antirheumatic Drugs Between Elderly-onset and Young-onset Rheumatoid Arthritis?
  • Abstract Number: 2651
    Are There Phenotypic Overlaps Between Giant Cell Arteritis Subgroups?
  • Abstract Number: 626
    Are There Really Differences Between Non-radiographic and Radiographic Axial Spondyloarthritis? Data from the Spanish Atlas
  • Abstract Number: 2319
    Are Vitamin D Metabolite Levels at Time of Diagnosis Associated with Long-term Severe Cardiovascular Events in Early Diagnosed Rheumatoid Arthritis Patients, Aggressively Treated During 10 Year Follow Up? Post-hoc Analyses of Observational Data from the CIMESTRA Cohort
  • Abstract Number: 1201
    Are We Meeting Benchmarks for Wait Times to Pediatric Rheumatology Care for Juvenile Idiopathic Arthritis (JIA)?
  • Abstract Number: PP06
    Art for Arthritis: A New Approach
  • Abstract Number: 620
    Arterial Elasticity by 2 Dimensional Circumferential Strain and Beta Stiffness Index in Patients with Ankylosing Spondylitis
  • Abstract Number: 2086
    Arthritis-Attributable Work Limitation Variation by U.S. County Classifications and Selected Characteristics, 2017
  • Abstract Number: 2062
    Arthritis, Physical Function, and Disability Among Older Mexican Americans over 20-Years of Follow-up
  • Abstract Number: 2063
    Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)
  • Abstract Number: 1817
    Arthropathy of Down Syndrome: An Under-diagnosed Inflammatory Joint Disease That Warrants a Name Change
  • Abstract Number: 564
    ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis
  • Abstract Number: 198
    Assessing Care Quality in Rheumatology Services
  • Abstract Number: 1900
    Assessing Commercial Titers of anti-Ro60 and Ro52 Antibodies to Risk Stratify Surveillance of Anti-Ro/SSA Antibody Positive Pregnancies
  • Abstract Number: 1597
    Assessing Long-term Poor Outcomes in Systemic Lupus Erythematosus Patients with Acute Coronary Syndromes
  • Abstract Number: 428
    Assessing Meaningful Changes in Disease Activity as Clinical Trial Efficacy Measures for Cutaneous Lupus Erythematosus
  • Abstract Number: 655
    Assessing Perceptions, Barriers, and Preferences to Exercise in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1079
    Assessing Psoriatic Arthritis Treatment Trends and Patient Journeys Between 2012 and 2018
  • Abstract Number: 1924
    Assessing Psychosocial Needs in Juvenile Dermatomyositis Patients Across the United Kingdom
  • Abstract Number: 2449
    Assessing Risk of PsA Progression: Results from a Combined Psoriasis-PsA Center Cohort
  • Abstract Number: 630
    Assessing the Humanistic and Economic Burden of Enthesitis Among Patients with Peripheral and Axial Spondyloarthritis: Results from a Multi-National Real World Survey Database
  • Abstract Number: 2765
    Assessing the Impact of Digital Health Coaching on Quality Adjusted Life Years, Symptom Severity and Disease Activity in Patients with Rheumatoid Arthritis
  • Abstract Number: 333
    Assessing the Relationship Between Gout and Return to Hemodialysis Among U.S. Renal Transplant Patients
  • Abstract Number: 2834
    Assessing the Risk of Gout with Sodium Glucose Co-Transporter-2 Inhibitors: A Population-Based Cohort Study
  • Abstract Number: 2755
    Assessing the Sensitivity to Change of the OMERACT Ultrasound Structural Gout Lesions During Urate-Lowering Therapy
  • Abstract Number: 1596
    Assessing the Validity of QRISK3 at Predicting Cardiovascular Events in Systemic Lupus Erythematosus Patients
  • Abstract Number: 295
    Assessing the Vascularization of Salivary Glands in Patients with Sjögren’s Syndrome – An OMERACT Ultrasound Group Reliability Exercise
  • Abstract Number: 496
    Assessment of Anti-Cyclic Citrullinated Protein and Connective Tissue Disease Screening Questionnaire in Healthy Adults from the Oklahoma Immune Cohort
  • Abstract Number: 528
    Assessment of Bone and Cartilage Turnover Markers Following Treatment with Repository Corticotropin Injection in Patients with Persistently Active Rheumatoid Arthritis
  • Abstract Number: 2214
    Assessment of Bone Quality by Trabecular Bone Score (TBS) in Systemic Lupus Erythematosus Patients
  • Abstract Number: 420
    Assessment of Fatigue in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Qualitative Study to Explore What Patients Feel Should Be Measured in Clinical Trials
  • Abstract Number: 949
    Assessment of Femoral Vein Wall Thickness with Doppler Ultrasound Can Be a Diagnostic Tool for Behcet’s Disease
  • Abstract Number: 1565
    Assessment of the QRISK2, QRISK3, SLE Cardiovascular Risk Equation, Framingham and Modified Framingham Risk Calculators as Predictors of Cardiovascular Disease Events in Systemic Lupus Erythematosus
  • Abstract Number: 1631
    Assessment of the Repeatability and Convergent Validity with Dermal Collagen of High Frequency Ultrasound in Systemic Sclerosis
  • Abstract Number: 1663
    Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis
  • Abstract Number: 2296
    Assisted Reproductive Technology in Patients with Inflammatory and Autoimmune Rheumatic Disease
  • Abstract Number: 743
    Association Between Acute-phase Reactants, interleukin-6(IL6), Tumor Necrosis Factor-a(TNFa) and Disease Activity in Takayasu’s Arteritis During Follow-up with Repeated Evaluation of Vascular Imaging Manifestations
  • Abstract Number: 670
    Association Between Ambient Air Pollutant Exposures and Childhood-Onset Systemic Lupus Erythematosus: A 12-Year Population-Based Cohort Study in Taiwan
  • Abstract Number: 2065
    Association Between Anemia and Hyperuricemia: Korean National Health and Nutrition Survey 2016-2017
  • Abstract Number: 1394
    Association Between Baseline Anti-CCP2 Antibody Concentration and Clinical Response After 6 Months of Treatment with Abatacept or a TNF Inhibitor in Biologic-Experienced Patients with RA: Results from a US National Observational Study
  • Abstract Number: 1386
    Association Between Baseline Anti-citrullinated Protein Antibody Status and Response to Abatacept or Non-TNF Inhibitor Therapy in Patients with RA: Results from a US National Observational Study
  • Abstract Number: 851
    Association Between Bone Marrow Edema and Structural Progression in the Same Quadrant in Axial Spondyloarthritis – 5-year Data from the DESIR Cohort
  • Abstract Number: 643
    Association Between Neutrophil to Lymphocyte, Monocyte to Lymphocyte, and Platelet to Lymphocyte Ratios and Lupus Disease Activity and Lupus Nephritis
  • Abstract Number: 2621
    Association Between Outcome Renal, Clinical Variables and Findings of Renal Biopsy in Patients with ANCA Vasculitis
  • Abstract Number: 635
    Association Between Radiographic Progression and Cardiovascular Risk in Spondyloarthritis: Data from CoSpaR REGISTRY
  • Abstract Number: 1892
    Association Between Rheumatoid Arthritis Treatment and the Risk of Death or Readmission After Major Surgery
  • Abstract Number: 1433
    Association Between Seropositivity and Discontinuation of Tumor Necrosis Factor Inhibitors Due to Insufficient Response in Rheumatoid Arthritis
  • Abstract Number: 2648
    Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy: A Retrospective, Single Center Experience over a 21 Years’ Period
  • Abstract Number: 686
    Association Between the Soluble Terminal Complement Complex C5b-9 (sC5b-9) and Signs of Active Kidney Disease in a Swiss SLE Cohort
  • Abstract Number: 2839
    Association of a Gout Polygenic Risk Score with Disease Severity Phenotypes Amongst Caucasian Gout Patients in Three Independent Cohorts
  • Abstract Number: 1606
    Association of African- American Ethnicity and Smoking Status and Total and Individual Damage Index in Systemic Lupus Erythematosus
  • Abstract Number: 2614
    Association of Body Composition in Scleroderma Patients with Disease Activity, Serum Levels of Inflammatory Cytokines and Parameters of Nutrition and Lipid Metabolism
  • Abstract Number: 2706
    Association of Body Mass Index with Juvenile Idiopathic Arthritis Disease Activity: A Portuguese and Brazilian Collaborative Analysis with Data from Reuma.pt Registry
  • Abstract Number: 616
    Association of Clinical and Radiographic Phenotype of Axial Spondyloarthritis and Skin Psoriasis: Results from the German Spondyloarthritis Inception Cohort
  • Abstract Number: 645
    Association of Co-positivity for Anti-dsDNA, -Nucleosome, and -Histone Antibodies and Disease Activity in Patients with Lupus Nephritis: Results from the KORNET Registry
  • Abstract Number: 580
    Association of Comorbidities with Disease Activity and Functional Impairment in Axial Spondyloarthritis: Results from a Nationwide Population-Based Study
  • Abstract Number: 701
    Association of Cumulative Urinary Podocyte Number and Urinary Podocalyxin with Long-term Renal Prognosis in Lupus Nephritis
  • Abstract Number: 1954
    Association of Functional (GA)n Microsatellite Polymorphism in the FLI1 Gene with Susceptibility to Human Systemic Sclerosis
  • Abstract Number: 2050
    Association of Gout with Vitamin D: A Population-Based Study
  • Abstract Number: 1881
    Association of Pain Centralization with DMARD Response in Active RA
  • Abstract Number: 2061
    Association of Periodontitis with Rheumatological Disorders: NHANES III Analysis
  • Abstract Number: 2315
    Association of Rheumatic Autoimmune Disease, Including Rheumatoid Arthritis, with Post-Traumatic Stress Disorder but Not Traumatic Brain Injury in Veterans
  • Abstract Number: 2331
    Association of Rheumatoid Arthritis-related Autoantibodies with Pulmonary Function Test Abnormalities in a Prospective Rheumatoid Arthritis Registry
  • Abstract Number: 661
    Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus
  • Abstract Number: 2342
    Association of Serum KL-6 Level and Change of Pulmonary Function in Interstitial Lung Disease of Rheumatoid Arthritis – Data from Prospective KOrean Rheumatoid Arthritis Interstitial Lung Disease (KORAIL) Study
  • Abstract Number: 2311
    Association of Sexual Dysfunction and Depression in Rheumatoid Arthritis Female Patients
  • Abstract Number: 1955
    Association of TERT and DSP Polymorphisms with Susceptibility to Myeloperoxidase-ANCA-Associated Vasculitis
  • Abstract Number: 2052
    Association of Traumatic Knee Injury with Knee Function, Symptoms, and Radiographic Osteoarthritis in Military Officers
  • Abstract Number: 2627
    Association of Work Productivity Assessed by Absenteeism and Presenteeism with Disease Activity, Damage and Health-related Quality of Life in Patients with ANCA-associated Vasculitis
  • Abstract Number: 2594
    Associations Between Antibodies to the Angiotensin II Type 1 Receptor and Endothelian-1 Type a Receptor and the Incidence of Vascular Complications in Early Diffuse Systemic Sclerosis
  • Abstract Number: 2178
    Associations Between Baseline and Longitudinal Quantitative Joint Space Width and Incident Hip Osteoarthritis: The Johnston County Osteoarthritis Project
  • Abstract Number: 175
    Associations Between Circulating Cytokines and Incident Inflammatory Arthritis in an Anti-citrullinated Protein Antibody Positive Population
  • Abstract Number: 210
    Associations of Clinical Biomarkers with Radiographic Progression of Rheumatoid Arthritis (RA) in African Americans with Early Disease
  • Abstract Number: 2362
    Associations of Disease-Modifying Anti-Rheumatic Drug (DMARD) Adherence with Time to First Biologic and Cycle Time on DMARDs, and Healthcare Utilization/Cost in a New RA Patient Cohort
  • Abstract Number: 1913
    Associations of HLA-B Alleles, Enthesitis and Peripheral Arthritis in Ankylosing Spondylitis
  • Abstract Number: 474
    Associations of Plasma Extravesicular (EV) MicroRNA Levels in Seropositive and Seronegative Rheumatoid Arthritis (RA)
  • Abstract Number: 191
    Associations of Self-Reported Inhalant Exposures with Autoantibodies and Disease Severity in U.S. Veterans with Rheumatoid Arthritis
  • Abstract Number: 345
    Associations of Serum Uric Acid with Cardiovascular Disease Risk: Data from the Korea National Health and Nutrition Examination Survey
  • Abstract Number: 2928
    Associations of Socioeconomic Status with Rheumatoid Arthritis (RA) Progression in African Americans with Early Disease
  • Abstract Number: 625
    Associations of Work-Related Abilities with Disability in Ankylosing Spondylitis
  • Abstract Number: 186
    Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study
  • Abstract Number: 2837
    Asymptomatic Monosodium Urate Crystal Deposition Associates with Increased Expression of Pro-Inflammatory Genes
  • Abstract Number: 2595
    Asymptomatic Scleroderma Antibody Positivity and Progression to Systemic Sclerosis
  • Abstract Number: 2223
    Attenuated Association Between Proton Pump Inhibitor Use and Fracture Risk After Consideration of Chronic Comorbidities
  • Abstract Number: 269
    Attitudes and Beliefs About Opioid Medications: Determining Treatment Use in Osteoarthritis
  • Abstract Number: 1401
    Australian Rheumatoid Arthritis (RA) Biologic Treatment Pathways: An Australian Rheumatology Association Database (ARAD) Analysis
  • Abstract Number: 881
    Auto-antibodies Targeting Components of Sarcolemma Repair: A Pathogenic Mechanism in Human Inflammatory Myopathies
  • Abstract Number: 2437
    Autoantibodies from Sjögren’s Syndrome Enhance NLRP3 Inflammasome Activation and IL-18 Production in Human Salivary Gland Cell Line A-253
  • Abstract Number: 960
    Autoantibodies in Rheumatoid Arthritis Target Citrulline-Containing and Native Epitopes from Conformationally Disordered Regions of Proteins
  • Abstract Number: 1884
    Autoantibodies to Malondialdehyde-acetaldehyde Preceding the Diagnosis of Rheumatoid Arthritis
  • Abstract Number: 2438
    Autoantibody Mediated Salivary Gland Hypofunction in Sjögren’s Syndrome Involves Activation of Innate Immunity and Endothelial Cells
  • Abstract Number: 404
    Autoantibody Profiles Delineate Three Distinct Subsets of Scleromyositis
  • Abstract Number: 1323
    Autologous Conditioned Serum and Plasma Rich in Growth Factors Show Stronger Evidence of Efficacy Than Other Kinds of Platelet-Rich Plasma
  • Abstract Number: 2074
    Automated Diagnosis Extraction from Electronic Medical Records with Machine Learning Classifiers
  • Abstract Number: 1642
    Automated Nailfold Capillary Counting System (AUTOCAPI) in Systemic Sclerosis Patients with Different Capillaroscopic Patterns
  • Abstract Number: 52
    Autophagy Protein Microtubule-associated Protein 1 Light chain-3B (LC3B) Regulates Joint Inflammation and Destruction in Rheumatoid Arthritis
  • Abstract Number: 38
    Autophagy Receptor Optineurin in Synovial Fibroblasts Plays a Protective Role Against Joint Destruction in Rheumatoid Arthritis
  • Abstract Number: 47
    Autoreactivity to Acetylated Histones Defines a Subset of RA Patients and Is Associated with Acetyl – Citrulline Anti-Modified Protein Autoantibody (AMPA) Cross-Reactivity
  • Abstract Number: 1828
    Avascular Necrosis Is Associated with APOL1 Variants in African Americans with Systemic Lupus Erythematosus
  • Abstract Number: 951
    Avoidable Acute Care Use for Vaccine-Preventable Illnesses Among Medicaid Beneficiaries with Lupus: Demographic and Healthcare Utilization Differences
  • Abstract Number: 430
    Axial Spondyloarthritis Patients Report Important Impairments in Daily Life and Work Ability – a Web Survey in 472 Patients
  • Abstract Number: 624
    Axial Spondyloarthritis: Knowledge, Screening and Referral Practices Amongst Primary Care Providers
  • Abstract Number: 2754
    AxSpA Patients with Symptom Onset < 30 Years Have More Structural Lesions on MRI of the Sacroiliac Joints When Fulfilling the Modified New York Criteria
  • Abstract Number: 1708
    Azathioprine and Glucocorticoid Combination Might Be a Good Treatment Option to Achieve Remission in Patients with IgG4-related Disease
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.